CCP-LETROZOLE

cellchem pharmaceuticals inc.🇨🇦 Health Canada

Approval Id: f8da82365e8ac9e0
Drug Approval Canada Name: CCP-LETROZOLE
Product Name: CCP-LETROZOLE
Status: Cancelled Post Market
Status Date: 2023-08-03
Original Market Date: 2017-07-24
Din: 02459884
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L02BG04 LETROZOLE
Atc Name: l 02 bg 04
Aig Number: 0132937001
Company Name: cellchem pharmaceuticals inc.
Company Address: UNIT 1, 30 Concourse Gate, Ottawa, Ontario, Canada, K2E 7V7

LETROZOLE

2.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f8da82365e8ac9e0

Type

Standard